Safia Costes received her PhD degree in Endocrinology in 2007 from the University of Montpellier, France. Before obtaining her current position as a tenured researcher, Dr. Costes completed a five-year postdoctoral fellowship (2008-2012) followed by a two-year position as an assistant researcher (2012-2014) at the Larry L. Hillblom Islet Research Center at the University of California - Los Angeles’s David Geffen School of Medicine (Prof. Peter C. Butler). Since 2015, she has been recruited as a researcher by the National Institute of Health and Medical Research in Montpellier (France), focusing her research on the physiopathology of pancreatic beta-cells.
Dr. Costes is the author or coauthor of more than 30 publications in different research areas such as diabetes, cell death, autophagy, signaling pathways. She is a member of the French Diabetes Society and the European Association for the Study of Diabetes. Dr. Costes’s main area of interest is pancreatic beta-cell dysfunction and apoptosis in type 2 diabetes.